Back to Search
Start Over
Network Pharmacology- and Molecular Docking-Based Identification of Potential Phytocompounds from Argyreia capitiformis in the Treatment of Inflammation.
- Source :
-
Evidence-based complementary and alternative medicine : eCAM [Evid Based Complement Alternat Med] 2022 Jan 31; Vol. 2022, pp. 8037488. Date of Electronic Publication: 2022 Jan 31 (Print Publication: 2022). - Publication Year :
- 2022
-
Abstract
- The methanolic extract of Argyreia capitiformis stem was examined for anti-inflammatory activities following network pharmacology analysis and molecular docking study. Based on gas chromatography-mass spectrometry (GC-MS) analysis, 49 compounds were identified from the methanolic extract of A. capitiformis stem. A network pharmacology analysis was conducted against the identified compounds, and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis and Gene Ontology analysis of biological processes and molecular functions were performed. Six proteins (IL1R1, IRAK4, MYD88, TIRAP, TLR4, and TRAF6) were identified from the KEGG pathway analysis and subjected to molecular docking study. Additionally, six best ligand efficiency compounds and positive control (aspirin) from each protein were evaluated for their stability using the molecular dynamics simulation study. Our study suggested that IL1R1, IRAK4, MYD88, TIRAP, TLR4, and TRAF6 proteins may be targeted by compounds in the methanolic extract of A. capitiformis stem to provide anti-inflammatory effects.<br />Competing Interests: The authors declare no conflicts of interest.<br /> (Copyright © 2022 Ahmad J. Obaidullah et al.)
Details
- Language :
- English
- ISSN :
- 1741-427X
- Volume :
- 2022
- Database :
- MEDLINE
- Journal :
- Evidence-based complementary and alternative medicine : eCAM
- Publication Type :
- Academic Journal
- Accession number :
- 35140801
- Full Text :
- https://doi.org/10.1155/2022/8037488